Serum BDNF levels and the antidepressant effects of electroconvulsive therapy with ketamine anaesthesia: a preliminary study

Serum BDNF levels and the antidepressant effects of electroconvulsive therapy with ketamine anaesthesia: a preliminary study

Objective To firstly examine the relationship between serum brain-derived neurotrophic factor (BDNF) levels and antidepressant response to ketamine as an anaesthesia in electroconvulsive therapy (ECT) in Chinese patients with treatment-refractory depression (TRD). Methods Thirty patients with TRD we...

Full description

Bibliographic Details
Main Authors:	Wei Zheng, Qiaomei Cen, Sha Nie, Minyi Li, Rong Zeng, Sumiao Zhou, Dongbin Cai, Miaoling Jiang, Xiong Huang
Format:	Article
Language:	English
Published:	PeerJ Inc. 2021-02-01
Series:	PeerJ
Subjects:	Electroconvulsive therapy Ketamine Depression Brain-derived neurotrophic factor
Online Access:	https://peerj.com/articles/10699.pdf

Similar Items

BDNF and the Antidepressant Effects of Ketamine and Propofol in Electroconvulsive Therapy: A Preliminary Study
by: Huang XB, et al.
Published: (2020-04-01)

Intravenous Ketamine Therapy vs. Electroconvulsive Therapy in Depressive Cases
by: Gholam Reza Kheirabadi, et al.
Published: (2012-01-01)

Subanesthetic dose of ketamine for the antidepressant effects and the associated cognitive impairments of electroconvulsive therapy in elderly patients—A randomized, double‐blind, controlled clinical study
by: Lei Zou, et al.
Published: (2021-01-01)

Comparative Effect of Intravenous Ketamine and Electroconvulsive Therapy in Major Depression: A Randomized Controlled Trial
by: Gholamreza Kheirabadi, et al.
Published: (2019-01-01)

Efficacy of Electroconvulsive Therapy and Ketamine Therapy in Major Depressive Disorder; A Comparative Study
by: Asif Azeem Bajwa, et al.
Published: (2023-02-01)

Comparison of the Effect of Propofol-Remifentanil versus Propofol-Ketamine on Hemodynamic Change and Seizure Duration in Electroconvulsive Therapy
by: Behzad Nazemroaya, et al.
Published: (2019-09-01)

Plasma BDNF concentrations and the antidepressant effects of six ketamine infusions in unipolar and bipolar depression
by: Wei Zheng, et al.
Published: (2021-03-01)

Comparison of the Effect of Ketamine and Sodium Thiopental on Blood Pressure and Heart Rate during Electroconvulsive Therapy in Patients Admitted to the Ward of Psychiatry; A Double-Blind Randomized Clinical Trial
by: Behzad Nazemroaya, et al.
Published: (2017-01-01)

Cognitive protective effect of subanesthetic ketamine anesthesia on elderly patients with depression undergoing electroconvulsive therapy: a prospective controlled clinical study
by: ZOU Lei, et al.
Published: (2021-02-01)

A Narrative Overview of Current Anesthetic Drugs in Electroconvulsive Therapy
by: Kevin Lee, et al.
Published: (2021-09-01)

Efficacy of propofol versus ketamine in modified electroconvulsive therapy: A prospective randomized control trial
by: Debarshi Guha, et al.
Published: (2022-01-01)

Anaesthesia for electroconvulsive therapy: An overview with an update on its role in potentiating electroconvulsive therapy
by: Pavan Kumar Kadiyala, et al.
Published: (2017-01-01)

Randomised controlled trial of ketamine augmentation of electroconvulsive therapy to improve neuropsychological and clinical outcomes in depression (Ketamine-ECT study)
by: Ian M Anderson, et al.
Published: (2017-03-01)

The Influence of Electroconvulsive Therapy (ECT) on Brain-Derived Neurotrophic Factor (BDNF) Plasma Level in Patients with Schizophrenia—A Systematic Review and Meta-Analysis
by: Anna Maria Szota, et al.
Published: (2023-09-01)

Induction of Bdnf from promoter I following electroconvulsive seizures contributes to structural plasticity in neurons of the piriform cortex
by: Anthony D. Ramnauth, et al.
Published: (2022-03-01)

Ketamine alters behavior and decreases BDNF levels in the rat brain as a function of time after drug administration
by: Daiane B. Fraga, et al.
Published: (2013-09-01)

The Immediate Early Gene Egr3 Is Required for Hippocampal Induction of Bdnf by Electroconvulsive Stimulation
by: Kimberly T. Meyers, et al.
Published: (2018-05-01)

Cognitive and Neurophysiological Recovery Following Electroconvulsive Therapy: A Study Protocol
by: Ben J. A. Palanca, et al.
Published: (2018-05-01)

A randomized, crossover comparison of ketamine and electroconvulsive therapy for treatment of major depressive episodes: a Canadian biomarker integration network in depression (CAN-BIND) study protocol
by: Jennifer L. Phillips, et al.
Published: (2020-06-01)

The influence of concomitant antidepressant and antipsychotic medication on antidepressant effect and seizure duration of electroconvulsive therapy
by: Sara Mohamad, et al.
Published: (2024-03-01)

Ketamine: A New Antidepressant?
by: Feride Karacaer
Published: (2015-03-01)

Changes in Adipokine, Resitin, and BDNF Concentrations in Treatment-Resistant Depression after Electroconvulsive Therapy
by: Agnieszka Permoda-Pachuta, et al.
Published: (2023-09-01)

Patients’, Carers’, and the Public’s Perspectives on Electroconvulsive Therapy
by: Chris Griffiths, et al.
Published: (2019-05-01)

Ketamine and Electroconvulsive Therapy: Better Together?
by: A. Fraga, et al.
Published: (2022-06-01)

The multiple faces of ketamine in anaesthesia and analgesia
by: Silvia Natoli
Published: (2021-04-01)

Electroconvulsive therapy knowledge and attitudes among patients and caregivers in South China: A preliminary study
by: Can-Jin Deng, et al.
Published: (2023-03-01)

Neurocognitive effects of six ketamine infusions and the association with antidepressant effects in treatment-resistant bipolar depression: a preliminary study
by: Wei Zheng, et al.
Published: (2020-11-01)

Ketamine as an alternative to ECT in catatonia in elderly women with bipolar disorder: A case report
by: Shanthi Sarma, et al.
Published: (2023-04-01)

Electroconvulsive therapy in the elderly and nonelderly: 10 years' retrospective comparison
by: Ravishankar Vinutha, et al.
Published: (2017-01-01)

Status epilepticus following electroconvulsive therapy
by: T M Omprakash, et al.
Published: (2013-01-01)

Molecular Biomarkers of Electroconvulsive Therapy Effects and Clinical Response: Understanding the Present to Shape the Future
by: Elisabetta Maffioletti, et al.
Published: (2021-08-01)

Clinical research progress on the antidepressant effects of ketamine
by: Fan Ni
Published: (2021-06-01)

Rapid and long-lasting antidepressant-like effects of ketamine and their relationship with the expression of brain enzymes, BDNF, and astrocytes
by: G.S.B. Viana, et al.
Published: (2020-12-01)

Analyses of anaesthesia with ketamine combined with different sedatives in rats
by: A.M. Molina, et al.
Published: (2015-07-01)

Immunoregulation and antidepressant effect of ketamine
by: Zhang Nan, et al.
Published: (2021-05-01)

Ketamine and the potential role for rapid-acting antidepressant medications
by: JH Krystal
Published: (2007-04-01)

EFFICACY OF ELECTROCONVULSIVE THERAPY IN TREATMENT - RESISTANT DEPRESSION
by: Nida Saleem, et al.
Published: (2018-08-01)

A comparative study of propofol, thiopentone sodium, and ketofol as induction agents for electro convulsive therapy
by: Nagraju R Gaddam, et al.
Published: (2021-01-01)

Acute antidepressant effects of intramuscular versus intravenous ketamine
by: Harihar Chilukuri, et al.
Published: (2014-01-01)

Electroconvulsive therapy (ECT) with ketamine induction for catatonia in an HIV positive patient
by: Yvette Nel, et al.
Published: (2023-01-01)